Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 180

1.

Characteristics and treatment regimens across ERS SHARP severe asthma registries.

van Bragt JJMH, Adcock IM, Bel EHD, Braunstahl GJ, Ten Brinke A, Busby J, Canonica GW, Cao H, Chung KF, Csoma Z, Dahlen B, Davin E, Hansen S, Heffler E, Horvath I, Korn S, Kots M, Kuna P, Kwon N, Louis R, Plaza V, Porsbjerg C, Ramos-Barbon D, Richards LB, Skrgat S, Sont JK, Vijverberg SJH, Weersink EJ, Yasinska V, Wagers SS, Djukanovic R, Maitland-van der Zee AH; SHARP CRC.

Eur Respir J. 2019 Oct 10. pii: 1901163. doi: 10.1183/13993003.01163-2019. [Epub ahead of print]

PMID:
31601713
2.

Assessing Adherence by Combining the Test of Adherence to Inhalers with Pharmacy Refill Records.

Plaza V, Giner J, Curto E, Alonso Ortiz MB, Orue MI, Vega JM, Cosío BG; Group of investigators of the RE-TAI study.

J Investig Allergol Clin Immunol. 2019 Oct 10:0. doi: 10.18176/jiaci.0461. [Epub ahead of print]

3.

Asthma, comorbidities, and aggravating circumstances. The GEMA-FORUM II task force.

Trigueros JA, Plaza V, Domínguez Ortega J, Serrano J, Cisneros C, Padilla A, Antón Gironés M, Mosteiro M, Martínez Moragón E, Olaguíbel Rivera JM, Delgado J, García Rivero JL, Martínez Rivera C, Garrido JJ, Quirce S; GEMAFORUM task force.

J Investig Allergol Clin Immunol. 2019 Oct 10:0. doi: 10.18176/jiaci.0460. [Epub ahead of print] No abstract available.

4.

Determinants and differences in satisfaction with the inhaler among patients with asthma or COPD.

Plaza V, Giner J, Curto E, Belén Alonso-Ortiz M, Itxaso Orue M, María Vega J, Cosío BG; group of investigators of the RE-TAI study (see annex file).

J Allergy Clin Immunol Pract. 2019 Oct 3. pii: S2213-2198(19)30846-3. doi: 10.1016/j.jaip.2019.09.020. [Epub ahead of print]

PMID:
31586668
5.

Breakpoint: Cell Wall And Glycoproteins And Their Crucial Role In The Phytopathogenic Fungi Infection.

Plaza V, Silva-Moreno E, Castillo L.

Curr Protein Pept Sci. 2019 Sep 6. doi: 10.2174/1389203720666190906165111. [Epub ahead of print]

PMID:
31490745
6.

DuoResp® Spiromax® adherence, satisfaction and ease of use: findings from a multi-country observational study in patients with asthma and COPD in Europe (SPRINT).

van der Palen J, Cerveri I, Roche N, Singh D, Plaza V, Gonzalez C, Patino O, Scheepstra I, Safioti G, Backer V.

J Asthma. 2019 Jul 11:1-9. doi: 10.1080/02770903.2019.1634097. [Epub ahead of print]

PMID:
31293211
7.

Survey of opinion of Spanish physicians on the role of eosinophils in asthma and other pathologies.

Plaza V, Blanco M, Delgado J, Martínez I, Zubeldía JM, Molina J.

J Investig Allergol Clin Immunol. 2019 Jun 7:0. doi: 10.18176/jiaci.0423. [Epub ahead of print] No abstract available.

8.

Is asthma in the elderly different? Functional and clinical characteristics of asthma in individuals aged 65 years and older.

Curto E, Crespo-Lessmann A, González-Gutiérrez MV, Bardagí S, Cañete C, Pellicer C, Bazús T, Vennera MDC, Martínez C, Plaza V.

Asthma Res Pract. 2019 Mar 19;5:2. doi: 10.1186/s40733-019-0049-x. eCollection 2019.

9.

Dilemmas and New Paradigms in Asthma Management.

Valero A, Olaguibel J, Delgado J, Plaza V, Álvarez F, Molina J, Mascarós E, Quirce S.

J Investig Allergol Clin Immunol. 2019 Feb;29(1):15-23. doi: 10.18176/jiaci.0345. Review.

10.

Clinical factors associated with the overuse of asthma rescue medication.

Urrutia I, Delgado J, Domínguez-Ortega J, Mascarós E, Pérez M, Resler G, Plaza V; on behalf on the MISTRAL Investigators Group.

J Investig Allergol Clin Immunol. 2019 Feb 11:0. doi: 10.18176/jiaci.0387. [Epub ahead of print]

11.

Asthma patient satisfaction with different dry powder inhalers.

Valero A, Ribó P, Maíz L, Barbero E, Calle M, Campo C, Rytilä P, Giner J, Plaza V.

Expert Rev Respir Med. 2019 Feb;13(2):133-138. doi: 10.1080/17476348.2019.1567339. Epub 2019 Jan 21.

PMID:
30625015
12.

Re-evolution of asthma management: dilemmas and new paradigms.

Valero A, Olaguibel J, Delgado J, Plaza V, Álvarez F, Molina J, Mascarós E, Quirce S.

J Investig Allergol Clin Immunol. 2018 Nov 9:0. doi: 10.18176/jiaci.0345. [Epub ahead of print] Review.

PMID:
30411701
13.

A Simple Score for Future Risk Prediction in Patients with Controlled Asthma Who Undergo a Guidelines-Based Step-Down Strategy.

Pérez de Llano L, García-Rivero JL, Urrutia I, Martínez-Moragón E, Ramos J, Cebollero P, Carballada F, Blanco-Aparicio M, Vennera MDC, Merino M, Torralba-García Y, Plaza V.

J Allergy Clin Immunol Pract. 2019 Apr;7(4):1214-1221.e3. doi: 10.1016/j.jaip.2018.10.017. Epub 2018 Oct 25.

PMID:
30368006
14.

Prevalence of Sleep Disorders in Adults With Down Syndrome: A Comparative Study of Self-Reported, Actigraphic, and Polysomnographic Findings.

Giménez S, Videla L, Romero S, Benejam B, Clos S, Fernández S, Martínez M, Carmona-Iragui M, Antonijoan RM, Mayos M, Fortuna A, Peñacoba P, Plaza V, Osorio RS, Sharma RA, Bardés I, Rebillat AS, Lleó A, Blesa R, Videla S, Fortea J.

J Clin Sleep Med. 2018 Oct 15;14(10):1725-1733. doi: 10.5664/jcsm.7382.

15.

Impact of patient satisfaction with his or her inhaler on adherence and asthma control.

Plaza V, Giner J, Calle M, Rytilä P, Campo C, Ribó P, Valero A.

Allergy Asthma Proc. 2018 Nov 18;39(6):437-444. doi: 10.2500/aap.2018.39.4183. Epub 2018 Oct 18.

16.

Pseudomonas aeruginosa in Chronic Obstructive Pulmonary Disease Patients with Frequent Hospitalized Exacerbations: A Prospective Multicentre Study.

Rodrigo-Troyano A, Melo V, Marcos PJ, Laserna E, Peiro M, Suarez-Cuartin G, Perea L, Feliu A, Plaza V, Faverio P, Restrepo MI, Anzueto A, Sibila O.

Respiration. 2018;96(5):417-424. doi: 10.1159/000490190. Epub 2018 Jul 24.

PMID:
30041176
17.

The MEGA Project: A Study of the Mechanisms Involved in the Genesis and Disease Course of Asthma. Asthma Cohort Creation and Long-Term Follow-Up.

Muñoz X, Álvarez-Puebla MJ, Arismendi E, Arochena L, Ausín MDP, Barranco P, Bobolea I, Cañas JA, Cardaba B, Crespo A, Del Pozo V, Domínguez-Ortega J, Fernandez-Nieto MDM, Giner J, González-Barcala FJ, Luna JA, Mullol J, Ojanguren I, Olaguibel JM, Picado C, Plaza V, Quirce S, Ramos D, Rial M, Romero-Mesones C, Salgado FJ, San-José ME, Sánchez-Diez S, Sastre B, Sastre J, Soto L, Torrejón M, Urnadoz M, Valdes L, Valero A, Cruz MJ.

Arch Bronconeumol. 2018 Mar 19. pii: S0300-2896(18)30009-7. doi: 10.1016/j.arbres.2017.12.012. [Epub ahead of print] English, Spanish.

18.

Identification of Pseudomonas aeruginosa and airway bacterial colonization by an electronic nose in bronchiectasis.

Suarez-Cuartin G, Giner J, Merino JL, Rodrigo-Troyano A, Feliu A, Perea L, Sanchez-Reus F, Castillo D, Plaza V, Chalmers JD, Sibila O.

Respir Med. 2018 Mar;136:111-117. doi: 10.1016/j.rmed.2018.02.008. Epub 2018 Feb 13.

PMID:
29501241
19.

Learning and Recall of Medical Treatment-Related Information in Older Adults Using the Differential Outcomes Procedure.

Plaza V, Molina M, Fuentes LJ, Estévez AF.

Front Psychol. 2018 Feb 14;9:157. doi: 10.3389/fpsyg.2018.00157. eCollection 2018.

20.

Mixed Th2 and non-Th2 inflammatory pattern in the asthma-COPD overlap: a network approach.

de Llano LP, Cosío BG, Iglesias A, de Las Cuevas N, Soler-Cataluña JJ, Izquierdo JL, López-Campos JL, Calero C, Plaza V, Miravitlles M, Torrego A, Martinez-Moragon E, Soriano JB, Viña AL, Bobolea I.

Int J Chron Obstruct Pulmon Dis. 2018 Feb 12;13:591-601. doi: 10.2147/COPD.S153694. eCollection 2018.

21.

Anxiety, Depression, and Asthma Control: Changes After Standardized Treatment.

Sastre J, Crespo A, Fernandez-Sanchez A, Rial M, Plaza V; investigators of the CONCORD Study Group.

J Allergy Clin Immunol Pract. 2018 Nov - Dec;6(6):1953-1959. doi: 10.1016/j.jaip.2018.02.002. Epub 2018 Feb 15.

PMID:
29454162
22.

Mucus hypersecretion in asthma is associated with rhinosinusitis, polyps and exacerbations.

Martínez-Rivera C, Crespo A, Pinedo-Sierra C, García-Rivero JL, Pallarés-Sanmartín A, Marina-Malanda N, Pascual-Erquicia S, Padilla A, Mayoralas-Alises S, Plaza V, López-Viña A, Picado C.

Respir Med. 2018 Feb;135:22-28. doi: 10.1016/j.rmed.2017.12.013. Epub 2018 Jan 3.

PMID:
29414449
23.

Errors in the Use of Inhalers by Health Care Professionals: A Systematic Review.

Plaza V, Giner J, Rodrigo GJ, Dolovich MB, Sanchis J.

J Allergy Clin Immunol Pract. 2018 May - Jun;6(3):987-995. doi: 10.1016/j.jaip.2017.12.032. Epub 2018 Jan 31.

PMID:
29355645
24.

The Role of FENO in the Diagnosis and Control of Asthma. Expert Multidisciplinary Group Debate during the Asthma Meeting Point 2017.

Plaza V, Cosio BG, Entrenas LM, Olaguíbel JM, Pérez de Llano L, Quirce S; miembros del Grupo Multidisciplinar del Asma Meeting Point (AMP) 2017.

Arch Bronconeumol. 2018 Apr;54(4):237-238. doi: 10.1016/j.arbres.2017.09.016. Epub 2017 Dec 20. English, Spanish. No abstract available.

25.

Accuracy of a New Algorithm to Identify Asthma-COPD Overlap (ACO) Patients in a Cohort of Patients with Chronic Obstructive Airway Disease.

Pérez de Llano L, Cosío BG, Miravitlles M, Plaza V; CHACOS study group.

Arch Bronconeumol. 2018 Apr;54(4):198-204. doi: 10.1016/j.arbres.2017.10.007. Epub 2017 Dec 9. English, Spanish.

26.

Update on questionnaires for assessing adherence to inhaler devices in respiratory patients.

Plaza V.

Curr Opin Allergy Clin Immunol. 2018 Feb;18(1):44-50. doi: 10.1097/ACI.0000000000000410. Review.

PMID:
29135485
27.

Asthma with bronchial hypersecretion: expression of mucins and toll-like receptors in sputum and blood.

Crespo-Lessmann A, Mateus E, Torrejón M, Belda A, Giner J, Vidal S, Sibila O, Plaza V.

J Asthma Allergy. 2017 Oct 12;10:269-276. doi: 10.2147/JAA.S142200. eCollection 2017.

28.

Concordance of opinions between patients and physicians and their relationship with symptomatic control and future risk in patients with moderate-severe asthma.

Crespo-Lessmann A, Plaza V, González-Barcala FJ, Fernández-Sánchez T, Sastre J.

BMJ Open Respir Res. 2017 Sep 13;4(1):e000189. doi: 10.1136/bmjresp-2017-000189. eCollection 2017.

29.

[Is the introduction of clinical management programs for patients with chronic obstructive pulmonary disease useful? Comparison of the effectiveness of two interventions on the clinical progress and care received].

Solanes I, Bolíbar I, Llauger MA, Peiro M, Valverde P, Fraga M, Medrano C, Bigorra T, Freixas M, Ligüerre I, Pou MA, Domínguez L, Valero C, Solà J, Giner J, Plaza V; el grupo de estudio del Proceso EPOC.

Aten Primaria. 2018 Mar;50(3):184-196. doi: 10.1016/j.aprim.2017.01.014. Epub 2017 Jul 21. Spanish.

30.

Multidisciplinary Consensus on the Nonadherence to Clinical Management of Inhaled Therapy in Spanish asthma patients.

López-Viña A, Giner J, Molina J, Palicio J, Plaza J, Quintano JA, Quirce S, Soria C, Uréndez AM, Plaza V.

Clin Ther. 2017 Aug;39(8):1730-1745.e1. doi: 10.1016/j.clinthera.2017.06.010. Epub 2017 Jul 12.

PMID:
28709688
31.

Fibromyalgia as a cause of uncontrolled asthma: a case-control multicenter study.

Martinez-Moragon E, Plaza V, Torres I, Rosado A, Urrutia I, Casas X, Hinojosa B, Blanco-Aparicio M, Delgado J, Quirce S, Sabadell C, Cebollero P, Muñoz-Fernández A.

Curr Med Res Opin. 2017 Dec;33(12):2181-2186. doi: 10.1080/03007995.2017.1354828. Epub 2017 Aug 11.

PMID:
28699806
32.

Impact of Asthma on the Sexual Functioning of Patients. A Case-Control Study.

Soto Campos JG, Rojas Villegas J, Padilla Galo A, Marina Malanda N, Garcia Rivero JL, Pinedo Sierra C, Garcia Salmones M, Cabrera Galán C, Segura Molina E, Plaza V, Pascual Erquicia S; Grupo Emergente de Asma (GEA) del Área de Asma de la SEPAR.

Arch Bronconeumol. 2017 Dec;53(12):667-674. doi: 10.1016/j.arbres.2017.05.011. Epub 2017 Jun 21. English, Spanish.

33.

Anti-Pseudomonas aeruginosa IgG antibodies and chronic airway infection in bronchiectasis.

Suarez-Cuartin G, Smith A, Abo-Leyah H, Rodrigo-Troyano A, Perea L, Vidal S, Plaza V, Fardon TC, Sibila O, Chalmers JD.

Respir Med. 2017 Jul;128:1-6. doi: 10.1016/j.rmed.2017.05.001. Epub 2017 May 2.

34.

Consensus on the Asthma-COPD Overlap Syndrome (ACOS) Between the Spanish COPD Guidelines (GesEPOC) and the Spanish Guidelines on the Management of Asthma (GEMA).

Plaza V, Álvarez F, Calle M, Casanova C, Cosío BG, López-Viña A, Pérez de Llano L, Quirce S, Román-Rodríguez M, Soler-Cataluña JJ, Miravitlles M.

Arch Bronconeumol. 2017 Aug;53(8):443-449. doi: 10.1016/j.arbres.2017.04.002. Epub 2017 May 8. English, Spanish.

35.

Motivational interviewing for adherence: post-training attitudes and perceptions of physicians who treat asthma patients.

Román-Rodríguez M, Ibarrola-Ruiz L, Mora F, Plaza V, Sastre J, Torrego A, Vega JM, Sánchez-Herrero G.

Patient Prefer Adherence. 2017 Apr 21;11:811-820. doi: 10.2147/PPA.S127645. eCollection 2017.

36.

Algorithm for identification of asthma-COPD overlap: consensus between the Spanish COPD and asthma guidelines.

Miravitlles M, Alvarez-Gutierrez FJ, Calle M, Casanova C, Cosio BG, López-Viña A, Pérez de Llano L, Quirce S, Roman-Rodríguez M, Soler-Cataluña JJ, Plaza V.

Eur Respir J. 2017 May 1;49(5). pii: 1700068. doi: 10.1183/13993003.00068-2017. Print 2017 May. No abstract available.

37.

Th-2 signature in chronic airway diseases: towards the extinction of asthma-COPD overlap syndrome?

Cosío BG, Pérez de Llano L, Lopez Viña A, Torrego A, Lopez-Campos JL, Soriano JB, Martinez Moragon E, Izquierdo JL, Bobolea I, Callejas J, Plaza V, Miravitlles M, Soler-Catalunya JJ; on behalf of the CHACOS study group.

Eur Respir J. 2017 May 1;49(5). pii: 1602397. doi: 10.1183/13993003.02397-2016. Print 2017 May.

38.

Quality Indicators of Asthma Care Derived From the Spanish Guidelines for Asthma Management (GEMA 4.0): A Multidisciplinary Team Report.

Quirce S, Delgado J, Entrenas LM, Grande M, Llorente C, López Viña A, Martínez Moragón E, Mascarós E, Molina J, Olaguibel JM, Pérez de Llano LA, Perpiñá Tordera M, Quintano JA, Rodríguez M, Román-Rodriguez M, Sastre J, Trigueros JA, Valero AL, Zoni AC, Plaza V; ASMAFORUM II Group.

J Investig Allergol Clin Immunol. 2017;27(1):69-73. doi: 10.18176/jiaci.0121. No abstract available.

39.

Multidisciplinary expert discussion. Uncontrolled asthma: causes, consequences and possible solutions

Plaza V, Quirce S, Delgado J, Martinez Moragón E, Pérez de Llano L; Grupo multidisciplinar de expertos "Asmaforum".

An Sist Sanit Navar. 2016 Nov 21;39(3):357-370. doi: 10.23938/ASSN.0233. Spanish.

40.

Near-fatal asthma: a heterogeneous clinical entity.

Serrano-Pariente J, Plaza V.

Curr Opin Allergy Clin Immunol. 2017 Feb;17(1):28-35. doi: 10.1097/ACI.0000000000000333. Review.

PMID:
27870665
41.

Asthma-chronic obstructive pulmonary disease overlap syndrome: a controversial concept.

Rodrigo GJ, Neffen H, Plaza V.

Curr Opin Allergy Clin Immunol. 2017 Feb;17(1):36-41. doi: 10.1097/ACI.0000000000000326. Review.

PMID:
27841767
42.

Asthma outcomes improve with continuous positive airway pressure for obstructive sleep apnea.

Serrano-Pariente J, Plaza V, Soriano JB, Mayos M, López-Viña A, Picado C, Vigil L; CPASMA Trial Group.

Allergy. 2017 May;72(5):802-812. doi: 10.1111/all.13070. Epub 2016 Nov 3.

43.

Test of Adherence to Inhalers.

Plaza V, López-Viña A, Cosio BG; en representación del Comité Científico del Proyecto TAI.

Arch Bronconeumol. 2017 Jul;53(7):360-361. doi: 10.1016/j.arbres.2016.08.006. Epub 2016 Oct 15. English, Spanish. No abstract available.

44.

[Identification of gaps in the clinical patient care of asthma in Spain. Results of the OPTIMA-GEMA survey].

Plaza V, Rodríguez del Río P, Gómez F, López Viña A, Molina J, Quintano JA, Quirce S, Soler R, Villa JR, Nieto A.

An Sist Sanit Navar. 2016 Mayo-Agosto;39(2):181-201. doi: 10.23938/ASSN.0274. Spanish.

45.

Recent Advances in the Study of the Plant Pathogenic Fungus Botrytis cinerea and its Interaction with the Environment.

Castillo L, Plaza V, Larrondo LF, Canessa P.

Curr Protein Pept Sci. 2017;18(10):976-989. doi: 10.2174/1389203717666160809160915. Review.

PMID:
27526927
46.

Attitudes and barriers uncontrolled asthma in Spain. Abanico study.

Martinez-Moragon E, Entrenas LM, Plaza V, Quirce S.

Rev Clin Esp. 2017 Jan - Feb;217(1):60-62. doi: 10.1016/j.rce.2016.06.008. Epub 2016 Jul 30. English, Spanish. No abstract available.

PMID:
27484344
47.

Pseudomonas aeruginosa resistance patterns and clinical outcomes in hospitalized exacerbations of COPD.

Rodrigo-Troyano A, Suarez-Cuartin G, Peiró M, Barril S, Castillo D, Sanchez-Reus F, Plaza V, Restrepo MI, Chalmers JD, Sibila O.

Respirology. 2016 Oct;21(7):1235-42. doi: 10.1111/resp.12825. Epub 2016 Jun 20.

PMID:
27325555
48.

Once-daily fluticasone furoate and vilanterol for adolescents and adults with symptomatic asthma: A systematic review with meta-analysis.

Rodrigo GJ, Plaza V.

Ann Allergy Asthma Immunol. 2016 Jun;116(6):565-70. doi: 10.1016/j.anai.2016.03.035. Epub 2016 Apr 23. Review.

PMID:
27117053
49.

Expression of toll-like receptors 2 and 4 in subjects with asthma by total serum IgE level.

Crespo-Lessmann A, Mateus E, Vidal S, Ramos-Barbón D, Torrejón M, Giner J, Soto L, Juárez C, Plaza V.

Respir Res. 2016 Apr 16;17:41. doi: 10.1186/s12931-016-0355-2.

50.

The Differential Outcomes Procedure Enhances Adherence to Treatment: A Simulated Study with Healthy Adults.

Molina M, Plaza V, Fuentes LJ, Estévez AF.

Front Psychol. 2015 Nov 20;6:1780. doi: 10.3389/fpsyg.2015.01780. eCollection 2015.

Supplemental Content

Support Center